Clinton Bybee, 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), bought 400,000 shares at $12.50 ($5.0M) on 2016-07-06, disclosed to the SEC on 2016-07-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| KRTX | BUY | 2019-07-02 | $1.6M | — | Filing → |
| PI | BUY | 2017-11-13 | $98K | — | Filing → |
| XCOM | BUY | 2015-11-18 | $1.5M | — | Filing → |